Carolinas HealthCare System
In this Section

Fourth International Workshop Speakers

The following individuals have graciously agreed to present their work.  Speakers listed in alphabetical order.

Matthew Alexander, PhD
Boston Children's Hospital

Generation, characterization, and drug compound screening of a zebrafish model of LGMD2I

Anthony Blaeser, PhD
Carolinas HealthCare System

Progressive impairment of cardiac function in FKRP P448L mutant mice
Sue Brown, PhD
Royal Veterinary College, University of London

Cajal-Retzius cell mislocalisation correlates with the severity of structural brain defects in mouse models of dystroglycanopathy

Kevin Campbell, PhD
University of Iowa
Mechanistic insights into glycosylation-deficient muscular dystrophy and therapeutic implications
Rachelle Crosbie, PhD
University of California Los Angeles

 

Tina Duong, PTD
Children's National Medical Center

Patient Reported Quality of Life Measures in Limb-Girdle Muscular Dystrophy:  Correlation with Clinical Outcomes
James Ervasti, PhD
University of Minnesota
Urinary biomarkers inform on muscular dystrophy pathogenesis
Minoru Fukuda, PhD
Sanford-Burnham Medical Research Institute
Laminin binding O-glycan depletion on α-dystroglycan in prostate cancer cells promote epithelial-mesenchymal transition and enhance perineural invasion

Amy Harper, MD
Carolinas HealthCare System

Madhuri Hegde, PhD
Emory University School of Medicine

 

Qi Lu, MD, PhD
Carolinas HealthCare System
Functional glycosylation of α-dystroglycan and muscle regeneration in FKRP mutant mice

Katherine Matthews, MD
University of Iowa Carver College of Medicine

Jerry Mendell, MD
The Research Institute at Nationwide Children's Hospital
Claudia Mitchell, PhD
LGMD2i Research Fund
LGMD2I Fund: Building and supporting programs to expedite the cure for Limb Girdle Muscular Dystrophy 2I
Glenn Morris, PhD
RJAH Orthopaedic Hospital and Keele University
New monoclonal antibodies against alpha-dystroglycan
Anne Rutkowski, MD
CureCMD
Tatsushi Toda, PhD
Kobe University
α-dystroglycanopathy and molecular targeting therapy 
Charles Vannoy, PhD
Carolinas HealthCare System
AAV-Mediated Gene Therapy for FKRP-related Muscular Dystrophies: Efficacy and Optimization
Kathryn Wagner, MD, PhD
Kennedy Krieger Institute
Steve Winder, PhD
University of Sheffield
Phosphorylation-dependent regulation of dystroglycan function
Bo Wu, PhD
Carolinas HealthCare System
Glucocorticoid steroid and bisphosphonate for FKRP related muscular dystrophy: Trials in FKRP mutant animal models
Xiao Xiao, PhD
University of North Carolina at Chapel Hill

Abstract Information

All speakers are asked to submit abstracts no later than February 14, 2015 at 11:59 p.m. eastern time.

Abstract Instructions:

  1. Submission: Please send completed abstracts to Anthony Blaeser at anthony.blaeser@carolinashealthcare.org no later than February 14, 2015.
  2. Title: The abstract title should be in sentence-style capitalization. Do not use all caps.
  3. Word limit: Abstracts should be kept to a 300 word limit.
  4. Formatting: Please submit abstract as a Word document.

If you have any questions regarding abstract submission please contact Anthony Blaeser at anthony.blaeser@carolinashealthcare.org.

About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity & Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.